Long Term Follow-up of Cervical Myelopathy Inpatients Treated With Integrated Complementary and Alternative Medicine
1 other identifier
observational
40
1 country
1
Brief Summary
Model of this study is a combined both retrospective chart review and follow up survey. Data of 4 hospitals will be used to find out the efficacy of conservative treatment in cervical myelopathy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 20, 2018
CompletedFirst Submitted
Initial submission to the registry
November 21, 2019
CompletedFirst Posted
Study publicly available on registry
November 22, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 19, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 19, 2020
CompletedAugust 10, 2022
August 1, 2022
2 years
November 21, 2019
August 8, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cervical spinal surgery status after discharge
The investigators will survey whether the patients had surgery after discharging from 4 hospitals(Haeundae Jaseng Korean Medicine Hospital, Jaseng Korean Medicine Hospital, Bucheon Jaseng Korean Medicine Hospital, and Incheon Jaseng Korean Medicine Hospital.
Finish survey by Jan 2020
Secondary Outcomes (8)
Cervical spinal surgery recommendations before hospitalization
Finish survey by Jan 2020
Symptom reoccurrence experience lasting for more than a month after treatment is closed
Finish survey by Jan 2020
Whether symptoms that are uncomfortable in daily life exists
Finish survey by Jan 2020
Whether currently being treated for neck or upper extremity symptoms
Finish survey by Jan 2020
Numeric Rating Scale of Neck and upper extremity pain
Finish survey by Jan 2020
- +3 more secondary outcomes
Interventions
Herbal medicine will be administered in water-based decoction (120ml) and dried powder (2g) form (Ostericum koreanum,Eucommia ulmoides, canthopanax sessiliflorus, Achyranthes japonica, Psoralea corylifolia, aposhnikovia divaricata, Cibotium barometz, Lycium chinense, Boschniakia rossica, Cuscuta chinensis, Glycinemax, Atractylodes japonica) at the physician's discretion.
Chuna is a Korean manual therapy directed at the spine and joints that incorporates various spinal manual medicine techniques for joint mobilization involving high-velocity, low amplitude thrusts to joints slightly beyond the passive range of motion and gentle force to joints within the passive range of movement. Chuna manual medicine will be administered to the pelvic, lumbar, thoracic, and cervical vertebrae at the physician's discretion.
Pharmacopuncture consisting of select herbal ingredients will be administered at Hyeopcheok (Huatuo Jiaji, EX B2), Ah-shi points and local acupuncture points using disposable injection needles (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea) at the physician's discretion.
Acupuncture treatment will be administered using mainly proximal acupuncture points and Ah-shi points.
Electroacupuncture treatment will be administered using mainly proximal acupuncture points and Ah-shi points.
Cupping treatment will be administered at 1-2 points using mainly proximal acupuncture points and Ah-shi points.
Patients will be allowed any other additional intervention(s) as deemed necessary regardless of type or dose, and patterns of use will be investigated and recorded as a pragmatic clinical study.
Eligibility Criteria
Patients who ended up the hospitalization and treatment in Haeundae Jaseng Korean Medicine Hospital, Jaseng Korean Medicine Hospital, Bucheon Jaseng Korean Medicine Hospital, Incheon Jaseng Korean Medicine Hospital
You may qualify if:
- Patients who had been hospitalized with symptoms of neurological defects such as muscle weakness in the upper extremity or sensory abnormalities, or impaired walking due to weakness in the lower extremity at Haeundae Jaseng Korean Medicine Hospital, Jaseng Korean Medicine Hospital, Bucheon Jaseng Korean Medicine Hospital and Incheon Jaseng Korean Medicine Hospital from Jan 2011 to Oct 2018.
- Patients diagnosed with 'Cervical myelopathy' finding and able to check the pressure and damage of the spinal cord (high signal shading) of the EMR imaging (T2-weighted MRI scan of C-spine)
- Patients who agreed voluntarily to participate in verbal consent
You may not qualify if:
- Patients whose chief complaint is not cervical myelopathy or who do not have the neurological defect of upper extremity or lower extremity
- If the cause of the neurological defect of the upper and lower extremities is not caused by the spine or tissue
- Patients who do not agree to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Haeundae Jaseng Hospital of Korean Medicine
Busan, 48102, South Korea
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
In-Hyuk Ha
Jaseng Medical Foundation
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Target Duration
- 8 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
November 21, 2019
First Posted
November 22, 2019
Study Start
November 20, 2018
Primary Completion
November 19, 2020
Study Completion
November 19, 2020
Last Updated
August 10, 2022
Record last verified: 2022-08